nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—Ulcerative stomatitis—Dactinomycin—germ cell cancer	0.0297	0.0297	CcSEcCtD
Darifenacin—Obstructive airways disorder—Methotrexate—germ cell cancer	0.0262	0.0262	CcSEcCtD
Darifenacin—Bladder pain—Bleomycin—germ cell cancer	0.0133	0.0133	CcSEcCtD
Darifenacin—Cerebrovascular accident—Vinblastine—germ cell cancer	0.0129	0.0129	CcSEcCtD
Darifenacin—Ulcerative stomatitis—Methotrexate—germ cell cancer	0.0129	0.0129	CcSEcCtD
Darifenacin—Mouth ulceration—Dactinomycin—germ cell cancer	0.0124	0.0124	CcSEcCtD
Darifenacin—Injury—Bleomycin—germ cell cancer	0.0116	0.0116	CcSEcCtD
Darifenacin—Cerebrovascular accident—Bleomycin—germ cell cancer	0.0109	0.0109	CcSEcCtD
Darifenacin—Mouth ulceration—Etoposide—germ cell cancer	0.00898	0.00899	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00897	0.00898	CcSEcCtD
Darifenacin—Pharyngitis—Vinblastine—germ cell cancer	0.00869	0.00869	CcSEcCtD
Darifenacin—Urinary retention—Ifosfamide—germ cell cancer	0.00868	0.00869	CcSEcCtD
Darifenacin—Breast disorder—Ifosfamide—germ cell cancer	0.00825	0.00825	CcSEcCtD
Darifenacin—Cerebrovascular accident—Cisplatin—germ cell cancer	0.00803	0.00804	CcSEcCtD
Darifenacin—Stomatitis—Bleomycin—germ cell cancer	0.00803	0.00803	CcSEcCtD
Darifenacin—Face oedema—Cisplatin—germ cell cancer	0.0076	0.0076	CcSEcCtD
Darifenacin—Stomatitis—Dactinomycin—germ cell cancer	0.00749	0.00749	CcSEcCtD
Darifenacin—Breast disorder—Cisplatin—germ cell cancer	0.00711	0.00712	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00709	0.00709	CcSEcCtD
Darifenacin—Infestation NOS—Ifosfamide—germ cell cancer	0.00704	0.00704	CcSEcCtD
Darifenacin—Infestation—Ifosfamide—germ cell cancer	0.00704	0.00704	CcSEcCtD
Darifenacin—Stomatitis—Ifosfamide—germ cell cancer	0.00686	0.00686	CcSEcCtD
Darifenacin—Pharyngitis—Dactinomycin—germ cell cancer	0.00684	0.00684	CcSEcCtD
Darifenacin—Hypertension—Vinblastine—germ cell cancer	0.00658	0.00658	CcSEcCtD
Darifenacin—Erythema multiforme—Dactinomycin—germ cell cancer	0.00652	0.00652	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.00636	0.00636	CcSEcCtD
Darifenacin—Hallucination—Ifosfamide—germ cell cancer	0.00629	0.00629	CcSEcCtD
Darifenacin—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00624	0.00624	CcSEcCtD
Darifenacin—Urethral disorder—Ifosfamide—germ cell cancer	0.00619	0.00619	CcSEcCtD
Darifenacin—Visual impairment—Ifosfamide—germ cell cancer	0.00609	0.00609	CcSEcCtD
Darifenacin—Erythema multiforme—Ifosfamide—germ cell cancer	0.00597	0.00598	CcSEcCtD
Darifenacin—Vaginal inflammation—Methotrexate—germ cell cancer	0.00595	0.00595	CcSEcCtD
Darifenacin—Stomatitis—Cisplatin—germ cell cancer	0.00591	0.00592	CcSEcCtD
Darifenacin—Eye disorder—Ifosfamide—germ cell cancer	0.0059	0.00591	CcSEcCtD
Darifenacin—Angiopathy—Ifosfamide—germ cell cancer	0.00573	0.00573	CcSEcCtD
Darifenacin—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00569	0.0057	CcSEcCtD
Darifenacin—Vaginal infection—Methotrexate—germ cell cancer	0.00562	0.00562	CcSEcCtD
Darifenacin—Cough—Bleomycin—germ cell cancer	0.00562	0.00562	CcSEcCtD
Darifenacin—Infestation NOS—Etoposide—germ cell cancer	0.00556	0.00556	CcSEcCtD
Darifenacin—Infestation—Etoposide—germ cell cancer	0.00556	0.00556	CcSEcCtD
Darifenacin—Mental disorder—Ifosfamide—germ cell cancer	0.00553	0.00554	CcSEcCtD
Darifenacin—Stomatitis—Etoposide—germ cell cancer	0.00542	0.00542	CcSEcCtD
Darifenacin—Bladder pain—Methotrexate—germ cell cancer	0.00538	0.00538	CcSEcCtD
Darifenacin—Mouth ulceration—Methotrexate—germ cell cancer	0.00538	0.00538	CcSEcCtD
Darifenacin—Urinary tract disorder—Cisplatin—germ cell cancer	0.00538	0.00538	CcSEcCtD
Darifenacin—Urethral disorder—Cisplatin—germ cell cancer	0.00534	0.00534	CcSEcCtD
Darifenacin—Constipation—Vinblastine—germ cell cancer	0.00532	0.00532	CcSEcCtD
Darifenacin—Pain—Vinblastine—germ cell cancer	0.00532	0.00532	CcSEcCtD
Darifenacin—Confusional state—Bleomycin—germ cell cancer	0.0053	0.0053	CcSEcCtD
Darifenacin—Anaphylactic shock—Bleomycin—germ cell cancer	0.00525	0.00525	CcSEcCtD
Darifenacin—Oedema—Bleomycin—germ cell cancer	0.00525	0.00525	CcSEcCtD
Darifenacin—Visual impairment—Cisplatin—germ cell cancer	0.00525	0.00525	CcSEcCtD
Darifenacin—Infection—Bleomycin—germ cell cancer	0.00522	0.00522	CcSEcCtD
Darifenacin—Vision blurred—Ifosfamide—germ cell cancer	0.00518	0.00518	CcSEcCtD
Darifenacin—Feeling abnormal—Vinblastine—germ cell cancer	0.00512	0.00513	CcSEcCtD
Darifenacin—Eye disorder—Cisplatin—germ cell cancer	0.00509	0.00509	CcSEcCtD
Darifenacin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00508	0.00509	CcSEcCtD
Darifenacin—Angioedema—Ifosfamide—germ cell cancer	0.00503	0.00503	CcSEcCtD
Darifenacin—Urinary tract disorder—Etoposide—germ cell cancer	0.00493	0.00493	CcSEcCtD
Darifenacin—Abdominal pain—Vinblastine—germ cell cancer	0.00492	0.00492	CcSEcCtD
Darifenacin—Mediastinal disorder—Cisplatin—germ cell cancer	0.00491	0.00491	CcSEcCtD
Darifenacin—Oedema—Dactinomycin—germ cell cancer	0.0049	0.0049	CcSEcCtD
Darifenacin—Urethral disorder—Etoposide—germ cell cancer	0.00489	0.00489	CcSEcCtD
Darifenacin—Infection—Dactinomycin—germ cell cancer	0.00487	0.00487	CcSEcCtD
Darifenacin—Palpitations—Ifosfamide—germ cell cancer	0.00486	0.00486	CcSEcCtD
Darifenacin—Cough—Ifosfamide—germ cell cancer	0.0048	0.0048	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00478	0.00479	CcSEcCtD
Darifenacin—Hypertension—Ifosfamide—germ cell cancer	0.00475	0.00475	CcSEcCtD
Darifenacin—Erythema multiforme—Etoposide—germ cell cancer	0.00472	0.00472	CcSEcCtD
Darifenacin—Dyspnoea—Bleomycin—germ cell cancer	0.00468	0.00468	CcSEcCtD
Darifenacin—Arthralgia—Ifosfamide—germ cell cancer	0.00468	0.00468	CcSEcCtD
Darifenacin—Flatulence—Cisplatin—germ cell cancer	0.00467	0.00467	CcSEcCtD
Darifenacin—Eye disorder—Etoposide—germ cell cancer	0.00466	0.00466	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00465	0.00465	CcSEcCtD
Darifenacin—Hypersensitivity—Vinblastine—germ cell cancer	0.00458	0.00458	CcSEcCtD
Darifenacin—Visual disturbance—Methotrexate—germ cell cancer	0.00456	0.00456	CcSEcCtD
Darifenacin—Angiopathy—Etoposide—germ cell cancer	0.00453	0.00453	CcSEcCtD
Darifenacin—Confusional state—Ifosfamide—germ cell cancer	0.00453	0.00453	CcSEcCtD
Darifenacin—Mediastinal disorder—Etoposide—germ cell cancer	0.0045	0.0045	CcSEcCtD
Darifenacin—Pain—Bleomycin—germ cell cancer	0.00449	0.00449	CcSEcCtD
Darifenacin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00449	0.00449	CcSEcCtD
Darifenacin—Oedema—Ifosfamide—germ cell cancer	0.00449	0.00449	CcSEcCtD
Darifenacin—Vision blurred—Cisplatin—germ cell cancer	0.00447	0.00447	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00446	0.00446	CcSEcCtD
Darifenacin—Asthenia—Vinblastine—germ cell cancer	0.00446	0.00446	CcSEcCtD
Darifenacin—Infection—Ifosfamide—germ cell cancer	0.00446	0.00446	CcSEcCtD
Darifenacin—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00441	0.00441	CcSEcCtD
Darifenacin—Nervous system disorder—Ifosfamide—germ cell cancer	0.0044	0.0044	CcSEcCtD
Darifenacin—Skin disorder—Ifosfamide—germ cell cancer	0.00436	0.00436	CcSEcCtD
Darifenacin—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00434	0.00434	CcSEcCtD
Darifenacin—Feeling abnormal—Bleomycin—germ cell cancer	0.00433	0.00433	CcSEcCtD
Darifenacin—Diarrhoea—Vinblastine—germ cell cancer	0.00425	0.00426	CcSEcCtD
Darifenacin—Dysgeusia—Etoposide—germ cell cancer	0.00425	0.00425	CcSEcCtD
Darifenacin—Back pain—Etoposide—germ cell cancer	0.0042	0.0042	CcSEcCtD
Darifenacin—Pain—Dactinomycin—germ cell cancer	0.00419	0.00419	CcSEcCtD
Darifenacin—Dizziness—Vinblastine—germ cell cancer	0.00411	0.00411	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00409	0.00409	CcSEcCtD
Darifenacin—Feeling abnormal—Dactinomycin—germ cell cancer	0.00404	0.00404	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00401	0.00401	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00401	0.00401	CcSEcCtD
Darifenacin—Dyspnoea—Ifosfamide—germ cell cancer	0.004	0.004	CcSEcCtD
Darifenacin—Somnolence—Ifosfamide—germ cell cancer	0.00399	0.00399	CcSEcCtD
Darifenacin—Vomiting—Vinblastine—germ cell cancer	0.00395	0.00395	CcSEcCtD
Darifenacin—Breast disorder—Methotrexate—germ cell cancer	0.0039	0.00391	CcSEcCtD
Darifenacin—Headache—Vinblastine—germ cell cancer	0.0039	0.0039	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00387	0.00388	CcSEcCtD
Darifenacin—Abdominal pain—Dactinomycin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Darifenacin—Anaphylactic shock—Cisplatin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Darifenacin—Oedema—Cisplatin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Darifenacin—Hypersensitivity—Bleomycin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Darifenacin—Infection—Cisplatin—germ cell cancer	0.00384	0.00385	CcSEcCtD
Darifenacin—Constipation—Ifosfamide—germ cell cancer	0.00384	0.00384	CcSEcCtD
Darifenacin—Pain—Ifosfamide—germ cell cancer	0.00384	0.00384	CcSEcCtD
Darifenacin—Loss of consciousness—Etoposide—germ cell cancer	0.00382	0.00382	CcSEcCtD
Darifenacin—Nervous system disorder—Cisplatin—germ cell cancer	0.00379	0.0038	CcSEcCtD
Darifenacin—Cough—Etoposide—germ cell cancer	0.00379	0.00379	CcSEcCtD
Darifenacin—Tachycardia—Cisplatin—germ cell cancer	0.00378	0.00378	CcSEcCtD
Darifenacin—Asthenia—Bleomycin—germ cell cancer	0.00377	0.00377	CcSEcCtD
Darifenacin—Skin disorder—Cisplatin—germ cell cancer	0.00376	0.00376	CcSEcCtD
Darifenacin—Hypertension—Etoposide—germ cell cancer	0.00375	0.00375	CcSEcCtD
Darifenacin—Hyperhidrosis—Cisplatin—germ cell cancer	0.00374	0.00374	CcSEcCtD
Darifenacin—Pruritus—Bleomycin—germ cell cancer	0.00372	0.00372	CcSEcCtD
Darifenacin—Feeling abnormal—Ifosfamide—germ cell cancer	0.0037	0.0037	CcSEcCtD
Darifenacin—Nausea—Vinblastine—germ cell cancer	0.00369	0.00369	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00367	0.00367	CcSEcCtD
Darifenacin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00367	0.00367	CcSEcCtD
Darifenacin—Hypersensitivity—Dactinomycin—germ cell cancer	0.00361	0.00361	CcSEcCtD
Darifenacin—Confusional state—Etoposide—germ cell cancer	0.00357	0.00358	CcSEcCtD
Darifenacin—Abdominal pain—Ifosfamide—germ cell cancer	0.00355	0.00355	CcSEcCtD
Darifenacin—Anaphylactic shock—Etoposide—germ cell cancer	0.00354	0.00355	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00353	0.00353	CcSEcCtD
Darifenacin—Infection—Etoposide—germ cell cancer	0.00352	0.00352	CcSEcCtD
Darifenacin—Asthenia—Dactinomycin—germ cell cancer	0.00351	0.00352	CcSEcCtD
Darifenacin—Tachycardia—Etoposide—germ cell cancer	0.00346	0.00346	CcSEcCtD
Darifenacin—Dyspnoea—Cisplatin—germ cell cancer	0.00345	0.00345	CcSEcCtD
Darifenacin—Skin disorder—Etoposide—germ cell cancer	0.00344	0.00344	CcSEcCtD
Darifenacin—Erectile dysfunction—Methotrexate—germ cell cancer	0.00344	0.00344	CcSEcCtD
Darifenacin—Hyperhidrosis—Etoposide—germ cell cancer	0.00343	0.00343	CcSEcCtD
Darifenacin—Diarrhoea—Dactinomycin—germ cell cancer	0.00335	0.00335	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00334	0.00334	CcSEcCtD
Darifenacin—Vomiting—Bleomycin—germ cell cancer	0.00334	0.00334	CcSEcCtD
Darifenacin—Infestation NOS—Methotrexate—germ cell cancer	0.00333	0.00333	CcSEcCtD
Darifenacin—Infestation—Methotrexate—germ cell cancer	0.00333	0.00333	CcSEcCtD
Darifenacin—Rash—Bleomycin—germ cell cancer	0.00331	0.00331	CcSEcCtD
Darifenacin—Pain—Cisplatin—germ cell cancer	0.00331	0.00331	CcSEcCtD
Darifenacin—Dermatitis—Bleomycin—germ cell cancer	0.00331	0.00331	CcSEcCtD
Darifenacin—Hypersensitivity—Ifosfamide—germ cell cancer	0.00331	0.00331	CcSEcCtD
Darifenacin—Stomatitis—Methotrexate—germ cell cancer	0.00325	0.00325	CcSEcCtD
Darifenacin—Asthenia—Ifosfamide—germ cell cancer	0.00322	0.00322	CcSEcCtD
Darifenacin—Sweating—Methotrexate—germ cell cancer	0.00319	0.00319	CcSEcCtD
Darifenacin—Feeling abnormal—Cisplatin—germ cell cancer	0.00319	0.00319	CcSEcCtD
Darifenacin—Pruritus—Ifosfamide—germ cell cancer	0.00318	0.00318	CcSEcCtD
Darifenacin—Dyspnoea—Etoposide—germ cell cancer	0.00316	0.00316	CcSEcCtD
Darifenacin—Somnolence—Etoposide—germ cell cancer	0.00315	0.00315	CcSEcCtD
Darifenacin—Nausea—Bleomycin—germ cell cancer	0.00312	0.00312	CcSEcCtD
Darifenacin—Vomiting—Dactinomycin—germ cell cancer	0.00311	0.00312	CcSEcCtD
Darifenacin—Rash—Dactinomycin—germ cell cancer	0.00309	0.00309	CcSEcCtD
Darifenacin—Diarrhoea—Ifosfamide—germ cell cancer	0.00307	0.00307	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00306	0.00306	CcSEcCtD
Darifenacin—Pain—Etoposide—germ cell cancer	0.00303	0.00303	CcSEcCtD
Darifenacin—Constipation—Etoposide—germ cell cancer	0.00303	0.00303	CcSEcCtD
Darifenacin—Dizziness—Ifosfamide—germ cell cancer	0.00297	0.00297	CcSEcCtD
Darifenacin—Pharyngitis—Methotrexate—germ cell cancer	0.00297	0.00297	CcSEcCtD
Darifenacin—Urinary tract disorder—Methotrexate—germ cell cancer	0.00295	0.00295	CcSEcCtD
Darifenacin—Urethral disorder—Methotrexate—germ cell cancer	0.00293	0.00293	CcSEcCtD
Darifenacin—Feeling abnormal—Etoposide—germ cell cancer	0.00292	0.00292	CcSEcCtD
Darifenacin—Nausea—Dactinomycin—germ cell cancer	0.00291	0.00291	CcSEcCtD
Darifenacin—Gastrointestinal pain—Etoposide—germ cell cancer	0.0029	0.0029	CcSEcCtD
Darifenacin—Visual impairment—Methotrexate—germ cell cancer	0.00288	0.00288	CcSEcCtD
Darifenacin—Vomiting—Ifosfamide—germ cell cancer	0.00285	0.00285	CcSEcCtD
Darifenacin—Hypersensitivity—Cisplatin—germ cell cancer	0.00285	0.00285	CcSEcCtD
Darifenacin—Rash—Ifosfamide—germ cell cancer	0.00283	0.00283	CcSEcCtD
Darifenacin—Dermatitis—Ifosfamide—germ cell cancer	0.00283	0.00283	CcSEcCtD
Darifenacin—Erythema multiforme—Methotrexate—germ cell cancer	0.00283	0.00283	CcSEcCtD
Darifenacin—Abdominal pain—Etoposide—germ cell cancer	0.0028	0.0028	CcSEcCtD
Darifenacin—Eye disorder—Methotrexate—germ cell cancer	0.00279	0.00279	CcSEcCtD
Darifenacin—Asthenia—Cisplatin—germ cell cancer	0.00278	0.00278	CcSEcCtD
Darifenacin—Angiopathy—Methotrexate—germ cell cancer	0.00271	0.00271	CcSEcCtD
Darifenacin—Mediastinal disorder—Methotrexate—germ cell cancer	0.00269	0.00269	CcSEcCtD
Darifenacin—Nausea—Ifosfamide—germ cell cancer	0.00267	0.00267	CcSEcCtD
Darifenacin—Diarrhoea—Cisplatin—germ cell cancer	0.00265	0.00265	CcSEcCtD
Darifenacin—Mental disorder—Methotrexate—germ cell cancer	0.00262	0.00262	CcSEcCtD
Darifenacin—Hypersensitivity—Etoposide—germ cell cancer	0.00261	0.00261	CcSEcCtD
Darifenacin—Dysgeusia—Methotrexate—germ cell cancer	0.00255	0.00255	CcSEcCtD
Darifenacin—Asthenia—Etoposide—germ cell cancer	0.00254	0.00254	CcSEcCtD
Darifenacin—Back pain—Methotrexate—germ cell cancer	0.00252	0.00252	CcSEcCtD
Darifenacin—Pruritus—Etoposide—germ cell cancer	0.00251	0.00251	CcSEcCtD
Darifenacin—Vomiting—Cisplatin—germ cell cancer	0.00246	0.00246	CcSEcCtD
Darifenacin—Vision blurred—Methotrexate—germ cell cancer	0.00245	0.00245	CcSEcCtD
Darifenacin—Rash—Cisplatin—germ cell cancer	0.00244	0.00244	CcSEcCtD
Darifenacin—Dermatitis—Cisplatin—germ cell cancer	0.00244	0.00244	CcSEcCtD
Darifenacin—Diarrhoea—Etoposide—germ cell cancer	0.00243	0.00243	CcSEcCtD
Darifenacin—Dizziness—Etoposide—germ cell cancer	0.00234	0.00234	CcSEcCtD
Darifenacin—Nausea—Cisplatin—germ cell cancer	0.0023	0.0023	CcSEcCtD
Darifenacin—Cough—Methotrexate—germ cell cancer	0.00227	0.00227	CcSEcCtD
Darifenacin—Vomiting—Etoposide—germ cell cancer	0.00225	0.00225	CcSEcCtD
Darifenacin—Rash—Etoposide—germ cell cancer	0.00224	0.00224	CcSEcCtD
Darifenacin—Dermatitis—Etoposide—germ cell cancer	0.00223	0.00223	CcSEcCtD
Darifenacin—Headache—Etoposide—germ cell cancer	0.00222	0.00222	CcSEcCtD
Darifenacin—Arthralgia—Methotrexate—germ cell cancer	0.00222	0.00222	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.0022	0.0022	CcSEcCtD
Darifenacin—Confusional state—Methotrexate—germ cell cancer	0.00214	0.00214	CcSEcCtD
Darifenacin—Anaphylactic shock—Methotrexate—germ cell cancer	0.00212	0.00212	CcSEcCtD
Darifenacin—Infection—Methotrexate—germ cell cancer	0.00211	0.00211	CcSEcCtD
Darifenacin—Nausea—Etoposide—germ cell cancer	0.00211	0.00211	CcSEcCtD
Darifenacin—Nervous system disorder—Methotrexate—germ cell cancer	0.00208	0.00208	CcSEcCtD
Darifenacin—Skin disorder—Methotrexate—germ cell cancer	0.00206	0.00206	CcSEcCtD
Darifenacin—Hyperhidrosis—Methotrexate—germ cell cancer	0.00205	0.00205	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00193	0.00194	CcSEcCtD
Darifenacin—Insomnia—Methotrexate—germ cell cancer	0.00192	0.00192	CcSEcCtD
Darifenacin—Dyspnoea—Methotrexate—germ cell cancer	0.00189	0.00189	CcSEcCtD
Darifenacin—Somnolence—Methotrexate—germ cell cancer	0.00189	0.00189	CcSEcCtD
Darifenacin—Dyspepsia—Methotrexate—germ cell cancer	0.00187	0.00187	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00183	0.00183	CcSEcCtD
Darifenacin—Pain—Methotrexate—germ cell cancer	0.00182	0.00182	CcSEcCtD
Darifenacin—Feeling abnormal—Methotrexate—germ cell cancer	0.00175	0.00175	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00174	0.00174	CcSEcCtD
Darifenacin—Abdominal pain—Methotrexate—germ cell cancer	0.00168	0.00168	CcSEcCtD
Darifenacin—Hypersensitivity—Methotrexate—germ cell cancer	0.00156	0.00156	CcSEcCtD
Darifenacin—Asthenia—Methotrexate—germ cell cancer	0.00152	0.00152	CcSEcCtD
Darifenacin—Pruritus—Methotrexate—germ cell cancer	0.0015	0.0015	CcSEcCtD
Darifenacin—Diarrhoea—Methotrexate—germ cell cancer	0.00145	0.00145	CcSEcCtD
Darifenacin—Dizziness—Methotrexate—germ cell cancer	0.0014	0.0014	CcSEcCtD
Darifenacin—Vomiting—Methotrexate—germ cell cancer	0.00135	0.00135	CcSEcCtD
Darifenacin—Rash—Methotrexate—germ cell cancer	0.00134	0.00134	CcSEcCtD
Darifenacin—Dermatitis—Methotrexate—germ cell cancer	0.00134	0.00134	CcSEcCtD
Darifenacin—Headache—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
Darifenacin—Nausea—Methotrexate—germ cell cancer	0.00126	0.00126	CcSEcCtD
Darifenacin—CHRM5—skin epidermis—germ cell cancer	5.17e-05	0.168	CbGeAlD
Darifenacin—CYP3A4—urine—germ cell cancer	1.96e-05	0.0637	CbGeAlD
Darifenacin—CYP2D6—urine—germ cell cancer	1.93e-05	0.0627	CbGeAlD
Darifenacin—CHRM5—eye—germ cell cancer	1.84e-05	0.0598	CbGeAlD
Darifenacin—CHRM5—skin of body—germ cell cancer	1.6e-05	0.052	CbGeAlD
Darifenacin—CHRM4—head—germ cell cancer	1.34e-05	0.0434	CbGeAlD
Darifenacin—CHRM4—testis—germ cell cancer	1.29e-05	0.0419	CbGeAlD
Darifenacin—CHRM2—telencephalon—germ cell cancer	1.15e-05	0.0374	CbGeAlD
Darifenacin—CHRM1—telencephalon—germ cell cancer	1.05e-05	0.0341	CbGeAlD
Darifenacin—CHRM5—head—germ cell cancer	1.05e-05	0.0339	CbGeAlD
Darifenacin—CHRM4—brain—germ cell cancer	9.69e-06	0.0315	CbGeAlD
Darifenacin—CHRM3—telencephalon—germ cell cancer	9.39e-06	0.0305	CbGeAlD
Darifenacin—CHRM5—brain—germ cell cancer	7.58e-06	0.0246	CbGeAlD
Darifenacin—CHRM2—endocrine gland—germ cell cancer	7.27e-06	0.0236	CbGeAlD
Darifenacin—CHRM2—head—germ cell cancer	7.18e-06	0.0233	CbGeAlD
Darifenacin—CHRM1—endocrine gland—germ cell cancer	6.62e-06	0.0215	CbGeAlD
Darifenacin—CHRM1—head—germ cell cancer	6.53e-06	0.0212	CbGeAlD
Darifenacin—CHRM3—female gonad—germ cell cancer	6.37e-06	0.0207	CbGeAlD
Darifenacin—CHRM3—endocrine gland—germ cell cancer	5.92e-06	0.0192	CbGeAlD
Darifenacin—CHRM3—head—germ cell cancer	5.85e-06	0.019	CbGeAlD
Darifenacin—CYP2D6—brainstem—germ cell cancer	5.72e-06	0.0186	CbGeAlD
Darifenacin—CHRM3—testis—germ cell cancer	5.65e-06	0.0183	CbGeAlD
Darifenacin—CHRM2—brain—germ cell cancer	5.2e-06	0.0169	CbGeAlD
Darifenacin—CYP2D6—telencephalon—germ cell cancer	5.08e-06	0.0165	CbGeAlD
Darifenacin—CHRM1—brain—germ cell cancer	4.73e-06	0.0154	CbGeAlD
Darifenacin—CHRM3—brain—germ cell cancer	4.24e-06	0.0138	CbGeAlD
Darifenacin—CYP2D6—female gonad—germ cell cancer	3.44e-06	0.0112	CbGeAlD
Darifenacin—CYP3A4—endocrine gland—germ cell cancer	3.25e-06	0.0106	CbGeAlD
Darifenacin—CYP2D6—endocrine gland—germ cell cancer	3.2e-06	0.0104	CbGeAlD
Darifenacin—CYP2D6—head—germ cell cancer	3.16e-06	0.0103	CbGeAlD
Darifenacin—CYP2D6—testis—germ cell cancer	3.05e-06	0.00991	CbGeAlD
Darifenacin—CYP2D6—cerebellum—germ cell cancer	2.82e-06	0.00916	CbGeAlD
Darifenacin—CYP2D6—brain—germ cell cancer	2.29e-06	0.00744	CbGeAlD
